FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Topics >> Alzheimer's

UC Irvine team: Alzheimer's vax shows promise

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!



Tools

Research presented this week at the Society for Neuroscience meeting showed one vaccine candidate appears both safe and effective in an animal model. A UC Irvine team tested a vaccine developed against a non-human protein that is similar to amyloid-beta but has a different sequence of amino acids. Because the protein in the vaccine is non-human, it's hoped that the vaccine would not cause inflammation. "The idea is if we can overcome this auto-inflammatory reaction, we might be able to develop a safe vaccine," said the senior author of the study, neuroscientist Charles Glabe of UC Irvine, at a news conference Tuesday in San Diego. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:
Be the first to comment
More stories about Alzheimer's  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.